EBOOK EBook-Why do new Therapies Succeed or fail in the Marketplace? How can decisions made during the preclinical phase of drug development increase the chances of a product’s eventual success in a difficult marketplace? To understand the factors that influence the early drug development journey for small molecules, Catalent and BioPharma Dive’s Brand Studio conducted an exclusive survey with participants from the pharma industry. Our industry report explores survey respondents’ opinions on why so many new drugs fail to deliver on their promise, and how they plan to avoid those pitfalls with their own compounds. LEARN MORE ABOUT: Why designing the optimal dose forms with advanced delivery technologies is critical to patient acceptance and adherence. The importance of engaging providers and payers. Suggestions for increasing the odds of success. BUSINESS EMAIL ADDRESS* FIRST NAME* LAST NAME* COMPANY* TITLE* BUSINESS PHONE COUNTRY* --Please Select-- Afghanistan Andorra Antigua and Barbuda Anguilla Albania Armenia Angola Antarctica Argentina Austria Australia Aruba Aland Islands Azerbaijan Bosnia and Herzegovina Barbados Bangladesh Belgium Burkina Faso Bulgaria Bahrain Burundi Benin Saint Barthélemy Bermuda Brunei Darussalam Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Brazil Bahamas Bhutan Bouvet Island Botswana Belarus Belize Canada Cocos (Keeling) Islands Congo, the Democratic Republic of the Central African Republic Congo Switzerland Cote d’Ivoire Cook Islands Chile Cameroon China Colombia Costa Rica Cuba Cape Verde Curaçao Christmas Island Cyprus Czech Republic Germany Djibouti Denmark Dominica Dominican Republic Algeria Ecuador Estonia Egypt Western Sahara Eritrea Spain Ethiopia Finland Fiji Falkland Islands (Malvinas) Faroe Islands France Gabon United Kingdom Grenada Georgia French Guiana Guernsey Ghana Gibraltar Greenland Gambia Guinea Guadeloupe Equatorial Guinea Greece South Georgia and the South Sandwich Islands Guatemala Guinea-Bissau Guyana Heard Island and McDonald Islands Honduras Croatia Haiti Hungary Indonesia Ireland Israel Isle of Man India British Indian Ocean Territory Iraq Iran, Islamic Republic of Iceland Italy Jersey Jamaica Jordan Japan Kenya Kyrgyzstan Cambodia Kiribati Comoros Saint Kitts and Nevis Korea, Democratic People’s Republic of Korea, Republic of Kuwait Cayman Islands Kazakhstan Lao People’s Democratic Republic Lebanon Saint Lucia Liechtenstein Sri Lanka Liberia Lesotho Lithuania Luxembourg Latvia Libyan Arab Jamahiriya Morocco Monaco Moldova, Republic of Montenegro Saint Martin (French part) Madagascar Macedonia, the former Yugoslav Republic of Mali Myanmar Mongolia Macao Martinique Mauritania Montserrat Malta Mauritius Maldives Malawi Mexico Malaysia Mozambique Namibia New Caledonia Niger Norfolk Island Nigeria Nicaragua Netherlands Norway Nepal Nauru Niue New Zealand Oman Panama Peru French Polynesia Papua New Guinea Philippines Pakistan Poland Saint Pierre and Miquelon Pitcairn Palestine Portugal Paraguay Qatar Reunion Romania Serbia Russian Federation Rwanda Saudi Arabia Solomon Islands Seychelles Sudan Sweden Singapore Saint Helena, Ascension and Tristan da Cunha Slovenia Svalbard and Jan Mayen Slovakia Sierra Leone San Marino Senegal Somalia Suriname South Sudan Sao Tome and Principe El Salvador Sint Maarten (Dutch part) Syrian Arab Republic Swaziland Turks and Caicos Islands Chad French Southern Territories Togo Thailand Tajikistan Tokelau Timor-Leste Turkmenistan Tunesia Tonga Turkey Trinidad and Tobago Tuvalu Taiwan Tanzania, United Republic of Ukraine Uganda United Arab Emirates United States Uruguay Uzbekistan Holy See (Vatican City State) Saint Vincent and the Grenadines Venezuela, Bolivarian Republic of Virgin Islands, British Viet Nam Vanuatu Wallis and Futuna Samoa Yemen Mayotte South Africa Zambia Zimbabwe BUYING HORIZON* -- Please Select -- Considering solutions for an immediate need Evaluating solutions for a project within 6 months Researching solutions for a project greater than 6 months away No need for a solution, just researching the topic BY SUBMITTING THIS DATA FORM, YOU CONSENT TO CATALENT COLLECTING AND PROCESSING THE INFORMATION YOU PROVIDED FOR OUR INTERNAL USE, IN ACCORDANCE WITH OUR PRIVACY POLICY. Why Catalent? Catalyst + Talent Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com. More products. Better treatments. Reliably supplied.™ Follow Us. Share Us. Copyright © 2021, Catalent, Inc - All Rights Reserved | Privacy | Terms This Website Uses Cookies By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy. Accept All Cookies Cookies Settings